Literature DB >> 24377633

Human papillomavirus genotypes and cervical cancer in northeast Thailand.

Sitakan Natphopsuk1, Wannapa Settheetham-Ishida, Chamsai Pientong, Supat Sinawat, Pissamai Yuenyao, Takafumi Ishida, Dariwan Settheetham.   

Abstract

Human papillomavirus (HPV) is a major cause of cervical cancer. More than 100 HPV genotypes have been identified; however the distribution varies geographically and according to ethnicity. The purpose of this study was to investigate the prevalence and distribution of HPV subtypes among Northeast Thai women. Subjects included 198 cases of SCCA and 198 age-matched, healthy controls. HPV-DNA was amplified by PCR using the consensus primers GP5+/6+ system followed by reverse line blot hybridization genotyping. The prevalence of high-risk HPV infection was 21 (10.1%) and 152 (76.8%) in the controls and in the cases, respectively. High-risk HPV significantly increased the risk for cervical cancer with an OR of 42.4 (95%CI: 22.4-81.4, p<0.001) and an adjusted OR of 40.7-fold (95%CI: 21.5-76.8, p <0.001). HPV-16 was the most prevalent HPV type in the SCCA (56.2%) followed by HPV-58 (17.8%) and HPV-18 (13.6%); whereas HPV-58 (46.4%) was a prominent genotype in the controls followed by HPV-16 (39.3%) and unidentified HPV types (25.0%). These findings indicate that HPV infection remains a critical risk factor for SCCA; particularly, HPV-16, HPV-58 and HPV-18. In order to eradicate cervical cancer, sustained health education, promoted use of prophylactics and a HPV-58 vaccine should be introduced in this region.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24377633     DOI: 10.7314/apjcp.2013.14.11.6961

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Molecular genotyping of human papillomavirus l1 gene in low-risk and high-risk populations in Bangkok.

Authors:  Pornsawan Leaungwutiwong; Busara Bamrungsak; Akanitt Jittmittraphap; Pannamas Maneekan; Nathamon Kosoltanapiwat; Thareerat Kalambaheti; James F Kelley
Journal:  Sex Transm Dis       Date:  2015-04       Impact factor: 2.830

2.  The Prevalence and Genotype Distribution of Human Papillomavirus in the Genital Tract of Males in Iran.

Authors:  Mostafa Salehi-Vaziri; Farzin Sadeghi; Farah Bokharaei-Salim; Sarang Younesi; Samaneh Alinaghi; Seyed Hamidreza Monavari; Hossein Keyvani
Journal:  Jundishapur J Microbiol       Date:  2015-12-18       Impact factor: 0.747

3.  HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability.

Authors:  Jun-Wei Zhao; Fang Fang; Yi Guo; Tai-Lin Zhu; Yun-Yun Yu; Fan-Fei Kong; Ling-Fei Han; Dong-Sheng Chen; Fang Li
Journal:  J Exp Clin Cancer Res       Date:  2016-11-25

4.  National and Subnational Population-Based Incidence of Cancer in Thailand: Assessing Cancers with the Highest Burdens.

Authors:  Shama Virani; Surichai Bilheem; Wasan Chansaard; Imjai Chitapanarux; Karnchana Daoprasert; Somsak Khuanchana; Atit Leklob; Donsuk Pongnikorn; Laura S Rozek; Surattaya Siriarechakul; Krittika Suwanrungruang; Sukit Tassanasunthornwong; Patravoot Vatanasapt; Hutcha Sriplung
Journal:  Cancers (Basel)       Date:  2017-08-17       Impact factor: 6.639

5.  Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq.

Authors:  Intisar Salim Pity; Hanaa Mohammed Abdo; Amer Abdalla Goreal
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

6.  Prevalence of human papillomavirus infection and genotyping for population-based cervical screening in developed regions in China.

Authors:  Yanru Zhang; Yueyun Wang; Li Liu; Chun Guo; Zhihua Liu; Shaofa Nie
Journal:  Oncotarget       Date:  2016-09-20

7.  Genetic Polymorphism of the Glutathione S-transferasezzm321990Pi 1 (GSTP1) and Susceptibility to Cervical Cancer in Humanzzm321990Papilloma Virus Infected Northeastern Thai Women

Authors:  Sophida Phuthong; Wannapa Settheetham-Ishida; Sitakan Natphopsuk; Takafumi Ishida
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.